Nurix Therapeutics (NASDAQ:NRIX) Price Target Raised to $30.00
Nurix Therapeutics (NASDAQ:NRIX – Free Report) had its price objective boosted by HC Wainwright from $26.00 to $30.00 in a report released on Monday, Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Nurix Therapeutics’ Q4 2024 earnings at ($0.67) EPS, FY2024 earnings at ($2.80) EPS, […]
25 Oct 07:51 · The Markets Daily